USPTO serial 79230436
Serial No. 79230436
Reviewed by CopyMark Law Group
Reg. 5759811Status 708Registered
- Filing date
- Status date
- Registration date
- May 28, 2019
- Examiner
- COLLOPY, DIANE PATRICIA
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with Serial No. 79230436?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Geza C Ziegler Jr
Geza C Ziegler Jr ZIEGLER IP LAW GROUP LLC.2000 Post Road, Suite 205Fairfield, CT 06824United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Pharmaceuticals for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders adapted for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical compositions for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders adapted for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical preparations for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical preparations for inhalers, namely, medical pharmaceutical compositions for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders structured for delivery into the body by nebulizer, aerosol, or dry powder, via the lungs or via the nasal passageway; Dietary supplements; Pharmaceutical products for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders ] | SECTION 71 - CANCELLED | — |
| 009 | Vials for scientific purposes being laboratory equipment; Vials for laboratory use; Glass tubes for scientific purposes being laboratory equipment, none of the aforesaid being additive manufacturing devices or 3D devices | ACTIVE | — |
| 010 | [ Surgical, medical, dental and veterinary apparatus and instruments, namely, injection devices for administering drugs sold empty; ] Medical apparatus for facilitating the inhalation of pharmaceutical preparations; [ Medical syringes sold empty for administering pharmaceuticals; ] Medical apparatus for introducing pharmaceutical preparations into the human body; Inhalers for medical use; Medical inhalers; [ Respiratory monitors for medical use; Apparatus for measuring lung function; Spirometers for examining the function of the lungs; Spirometers; Spirometer mouth pieces and tubing; breath gas analyzers for medical diagnostics; ] Replacement cartridges for medical inhalers sold empty; Nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of asthma and respiratory diseases | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the field of drug delivery via the lungs or via the nasal passageway; Scientific and technological design of new products for others; Advisory services relating to design engineering; Advisory services relating to product testing; Product design and development in the field of drug delivery via the lungs or via the nasal passageway; New product design services, namely, analysis and evaluation of product design; engineering design and consultancy; Professional consultancy relating to medical technology; engineering project management services, not for business purposes; Engineering research; Pharmaceutical research and development services; research and development for the pharmaceutical industry; Research relating to medicines; none of the aforesaid in relation to additive manufacturing services or 3D printing services | ACTIVE | — |
| 044 | Pharmaceutical compounding services; Pharmaceutical compounding consultation services; Pharmaceutical compounding advisory services; Medical services [ ; Veterinary services; Hygienic and beauty care for animals; Hygienic and beauty care for humans ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Merxin Ltd
- Other trademarks owned by Merxin Ltd
- Other trademarks owned by Merxin Ltd
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 14, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 14, 2025 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Oct 14, 2025 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Oct 13, 2025 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Oct 3, 2025 | PR75 | POST REGISTRATION ACTION MAILED - SEC. 71 & 15 | — |
| Oct 3, 2025 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Aug 27, 2025 | PR75 | POST REGISTRATION ACTION MAILED - SEC. 71 & 15 | — |
| Aug 25, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 22, 2025 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| May 16, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 16, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 16, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 16, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 16, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 16, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 16, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 28, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 27, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 9, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 9, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 28, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 14, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 28, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 24, 2019 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Mar 8, 2019 | ISMR | WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST | — |
| Feb 12, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 12, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 8, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 23, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 23, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 23, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 21, 2018 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Dec 20, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 20, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 20, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 19, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 19, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 19, 2018 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 13, 2018 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Nov 2, 2018 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Aug 1, 2018 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 1, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 26, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 25, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 25, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 20, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 1, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 1, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 29, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 28, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 27, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 24, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 20, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 19, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |